Molecular Diagnostics
Gene Test Identifies Patients with High Risk Colon Cancer
Proprietary microarray-based gene signature marker can identify patients' recurrence risk within five years after surgery and guides adjuvant chemotherapy treatment decisions. Colon cancer is the second leading cause of cancer mortality among men and women in the USA and the five-year survival rate for individuals with colon cancer is 64.9%. More...11 Apr 2016
Improved “Liquid Biopsy” Technique Enhances Tumor DNA Detection
An improved method has been devised to significantly increase the sensitivity of a technique to identify and sequence DNA from cancer cells circulating in a person's blood. The hope is that such "liquid biopsies" of easily obtained blood samples could one day replace the need to surgically obtain tumor tissue for examination. More...10 Apr 2016
Noncoding RNA Gene Linked to Malignant Melanoma
While a large share of the human genome has long been considered “junk DNA” because it does not contribute to protein coding, recent insights indicate that it does produce many noncoding ribonucleic acids that play important roles in essential biological processes and diseases. More...05 Apr 2016
Novel Blood Test Detects Colorectal Cancer Recurrence Earlier
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide, accounting for more than 600,000 deaths each year. When diagnosed early, before cancer has spread, the relative five-year survival rate for CRC is 90%, but only about 4 out of 10 CRC cases are detected early. More...05 Apr 2016
Hereditary Cancer Test Identifies Deleterious Mutations in Endometrial Cancer
Two recent studies have shown that a Hereditary Cancer test can identify deleterious mutations in patients with endometrial cancer and additionally, showed the superior ability of the combined three biomarker test to predict survival in patients with platinum treated ovarian cancer. More...05 Apr 2016
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Clinical Chemistry System
P780
Laboratory Software
ArtelWare
In Other News
Multigene Test Identifies Early Breast Cancer
Blood Test Gives Early Warning of Melanoma Relapse
Robust Method Developed for Microbiome Analysis
Biomarker Identifies Uveal Melanoma Patients at Risk for Metastasis
Ultrasensitive Antibody Detection Enabled by Agglutination-PCR
Whole-Exome Sequencing Identifies Rare Inherited Diseases
Gene Predicts Outcomes for Head and Neck Patients
Genomic Analyses Identifies Molecular Subtypes of Pancreatic Cancer
Biomarkers Help Diagnose Mild Cognitive Impairment in Diabetics
New Protocol Rapidly Detects Three Legionella Species
Blood Test Developed to Detect Five Early-Stage Cancers
Blood Test Detects All Known Inherited Heart Conditions Genes
Tumor Biopsies with Blood Monitoring Show Lesion-Specific Response
Molecular Type 2 Diabetes Biomarker Identified
Nanotechnology Helps Detects Biomarkers of Cancer
Gene Mutation Provides Clue to Vibratory Urticaria
Fast and Accurate Cystic Fibrosis Test Developed for Newborns
Listeria Hypervirulence Uncovered by Harnessing Its Biodiversity
Prognostic Biomarker Found for Colon Cancer Patients
Blood Test Improves Treatment for Acute Myeloid Leukemia
Aberrant Gene Expression Predicts Metastatic Endometrial and Lung Cancers
Fungal Infection Identified by Pathogen Detection Array Technology
Rapid Test Accurately Profiles Brain Tumor Genetics
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
